疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

/ `( m  A4 d; sApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
4 ~; D# ?4 }8 ^% w6 l
http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606
8 F" g) ]2 b# L/ ]! E) d6 P* b
$ |3 }: V6 c' @8 Z8 Y) F* ]SECTION 1: General aspects of vaccination
& B2 ~/ z2 J$ R% \4 J& U1 t7 d1 A short history of vaccination 1
2 Vaccine immunology 14
! j# g3 B: T3 |" s! I& b9 o9 @" r3 The vaccine industry 33
) Y) C. }# I3 I: l& s/ g$ m4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 h7 ~; i) h& ~+ s' t6 Vaccine additives and manufacturing residuals in the United States:
6 _# L( ~6 f( J: Q4 ylicensed vaccines 71
2 Y) ~+ ]' M* U7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
9 I+ X- C+ p; n' j9 Adenovirus vaccines 113
# C1 ^. m$ @7 @10 Anthrax vaccines 127
- k8 O* e& M9 \- {& o# A: I11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
' r. |2 I( o8 K, M5 h2 ?14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
+ K  w1 g1 h6 m$ z16 Human papillomavirus vaccines 235
3 b. L  g" ~+ p17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
4 D( ~: M! S2 F7 b22 Mumps vaccine 419
4 e- K) G" W* w& `' J1 s23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
. A3 ]. v3 s; |& [4 S+ P) w" }+ d26 Pneumococcal polysaccharide vaccines 542
; c+ Z7 n! r2 z$ w+ F9 F- _8 x27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
+ r1 }; a' o0 K  a' c& t/ g29 Rabies vaccines .646
! d3 I- o1 R% M0 e' v% u& b30 Rotavirus vaccines . 669
31 Rubella vaccine 688
# K1 ~6 E$ ~  `+ I3 o! Z) q32 Smallpox and vaccinia 718
, b# p( u0 |  `6 S& ?, ]8 ~; w8 q33 Tetanus toxoid 746
  S4 H7 V4 T% p  ~; T34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
5 {$ A0 _( r8 M: G' \8 p* H6 r! o36 Typhoid fever vaccines 812
1 ~! R2 |- R* d6 t37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
40 Combination vaccines 981
# J8 J# \. Q& }SECTION 3: Vaccines in development and new vaccine strategies
: V8 S8 J+ H$ Q. Y41 Biodefense and special pathogen vaccines 1008
% \2 y( v% n/ v! m42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
  S* z* R2 P, I, a, k44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
7 ?* Y* w5 ]$ R% v3 G47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
3 K$ o  f: U- ]51 Human immunodeficiency virus vaccines 1097
$ G1 j9 K5 e5 E52 Lyme disease vaccines 1122
$ [& l; v+ F0 R, S  e6 J7 j53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
4 o# p) P1 P) h! u# H; Z, x55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
% Q" @1 J3 i9 ]57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
$ |( z: A& q0 @) d6 r5 g1 N5 \61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
8 M  Q( ]: Q- c' c4 h9 \SECTION 4: Vaccination of special groups
# G7 V% @0 i! g( o  v/ S$ ?63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
" \% Y6 d$ V) Z3 w. \2 E66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
- h; t9 x  b% @' P6 Y0 n; s68 Immunization in Europe . 1334
3 v: _$ a7 ~$ x6 T' W69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
( F  p6 j; P# J& Q5 w' A73 Regulation and testing of vaccines 1427
& @  h. k" j* i) T74 Regulation of vaccines in Europe 1447
) F' U7 A0 i4 U7 x' `75 Regulation of vaccines in developing countries 1454
- j, l7 J" i( F0 E0 O76 Vaccine safety 1464
5 i, e+ o+ i0 D% s5 ]77 Legal issues . 1481
78 Ethics 1508
. z  A" M5 J, I



, J9 l4 v4 N  m. Y) D" _

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

" L3 Y- W9 U3 y8 ~Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
4 w* R: V% N. X( ?6 H3 ?8 \
( q5 U% V4 T8 W! Nhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
/ Y' u: I$ p1 ?5 B1 }
; k/ u7 m5 Q, h. l" E# lSECTION 1: General aspects of vaccination
( t: d4 D8 w  \- C* r$ x$ c1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
: r% D4 }+ O1 N# I. r6 k) ]3 c4 Vaccine manufacturing 44
* _9 A0 D% ^% T% E/ L) t5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
2 f* l4 J; T0 B3 [$ b3 g4 L5 P2 U& v+ Llicensed vaccines 71
/ D+ }( D  A. g+ j+ |7 Passive immunization 80
. H* ^3 _" V$ l/ Z2 x8 General immunization practices 88
3 q0 C7 P: i5 I/ I* ?SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
! M1 @  n. ]2 `  ]* H% C+ E$ }( f10 Anthrax vaccines 127
11 Cholera vaccines 141
% r8 A. j! q3 v4 p( M% p2 a: `12 Diphtheria toxoid 153
$ f; h! W* l/ T2 H! z' E4 z13 Haemophilus influenzae vaccines 167
: k( E) L/ f9 [4 j9 j- |14 Hepatitis A vaccines 183
7 ~$ Q& h; t% s9 L) }15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
+ [. S3 p9 |4 s17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
0 y! J: i3 X9 |7 m- c- H+ N21 Meningococcal vaccines 388
22 Mumps vaccine 419
9 e0 H- H! D" T2 V/ Y, o23 Pertussis vaccines . 447
24 Plague vaccines 493
! U  Y" O' F3 E' ^25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
) E5 w" x6 V9 k  \* p26 Pneumococcal polysaccharide vaccines 542
' q, x3 K, Z& L/ Y  |" i27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
5 q7 N. U1 w7 h, b31 Rubella vaccine 688
+ j0 U* f. W1 g3 c/ t* T32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
% A, [/ S  X) i/ C' W3 q35 Tuberculosis vaccines 789
4 [! r& |5 _, a36 Typhoid fever vaccines 812
+ d# ^# c6 [7 M37 Varicella vaccine 837
- b" I3 e5 g8 X; f$ `38 Yellow fever vaccine 870
39 Zoster vaccine 969
8 g1 x* v$ d# g* l40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
2 p: [" Q4 h& P( ?9 P, I6 X41 Biodefense and special pathogen vaccines 1008
+ p- \$ H1 o% {. Q( H42 Therapeutic cancer vaccines 1018
- Z* h5 t3 n  e2 r43 Cytomegalovirus vaccines 1032
; F; k0 r& K. |8 I' d0 K44 Dengue vaccines 1042
9 R2 H1 X. ]4 j, t9 W6 X% B, T3 h45 Diarrhea caused by bacteria 1052
  F7 l  j4 q6 B7 r+ m' s0 B* O8 k0 q46 Ebola vaccine 1060
$ I6 N' J2 E1 G6 T; M47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
! l; y" c; w( Y- X50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
1 a) z9 L8 k7 g0 N( L) v; _55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
: S2 ]! s! g, b3 e+ k. f; f56 Parasitic disease vaccines 1154
6 h; j7 T& z; P5 d# F* H7 h" |57 Staphylococcus aureus vaccines 1161
0 o4 M+ |7 f3 y) ]8 Z58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
$ \, j( O1 S1 r! o7 h  U7 o% E! |60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
* \+ C. F' D% F# K% C2 P* u& c9 M$ I64 Vaccination of human immunodeficiency virus-infected persons 1257
0 K0 u2 k# {  v/ k6 ~65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
% |" N, U8 W0 b* p' B' k; n67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
+ w+ G7 S  \. e' ~, a71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
' t& ^4 L& |# E" Q& h5 e" |3 {5 I74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
! e3 `, E. v* n( \7 P2 u78 Ethics 1508
3 |& S1 \% P0 ?- p7 s
9 @$ \8 k2 i$ D. p; {0 K  k
* Y6 P; V8 j9 ~. E

casarett

Vaccines, 6e, 2012
+ ]* q* I( C. ]- D7 m8 M$ l, e
Hardcover: 1570 pages
0 [- l1 ?* o( }; Q. u2 {Publisher: Saunders; 6 edition (October 30, 2012)
: v- j/ j* @4 M$ eLanguage: English
* |. |/ b4 W# t8 u- a' uISBN-10: 1455700908
$ z; _3 S9 G! |, _4 y" [. S: {Size: 52.3mb (original pdf)

- `1 J: M0 [3 f- x; s/ Q0 H* Q, o2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
  t8 @. A: `4 r
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
2 @  b& ?, G7 SUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
1 c* _5 |  Q. c2 r/ Z8 R: @Analyze the cost-benefit and cost-effectiveness of different vaccine options.
Clearly visualize concepts and objective data through an abundance of tables and figures.
$ Y* D3 y' H/ O; p; \$ ^! QPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
/ H- M# v# B0 u
Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
- ^: J! o( |3 s- S( G